What is the appropriate management for a 22‑year‑old patient with acute fulminant hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Acute Fulminant Hepatitis in a 22-Year-Old

Immediately transfer this patient to an intensive care unit at a liver transplant center, establish the etiology through comprehensive testing, provide supportive care, and urgently list for liver transplantation if poor prognostic criteria are met. 1

Critical Initial Actions

Immediate Transfer and Monitoring

  • Transfer to a specialized ICU with liver transplant capability immediately 1, 2
  • This is non-negotiable—mortality without specialized care approaches 75-80% 3
  • Begin continuous cardiorespiratory and neurological monitoring 4

Establish Etiology Urgently

Viral hepatitis workup:

  • Hepatitis A IgM, HBsAg, anti-HBc IgM, Hepatitis E IgM (especially if recent travel to endemic areas) 1
  • HSV-1/2 PCR, VZV serology (even without skin lesions—present in only 50% of cases) 1
  • If HSV/VZV suspected: start IV acyclovir immediately and list for transplant 1

Drug/toxin history:

  • Document ALL medications, herbs, supplements taken in past year with exact timing 1
  • Discontinue all non-essential medications immediately 1
  • Acetaminophen level (even if denied ingestion)

Age-specific critical tests for a 22-year-old:

  • Wilson disease screening is mandatory at this age: ceruloplasmin, 24-hour urinary copper, serum copper, slit-lamp exam for Kayser-Fleischer rings 1
  • Look for hemolytic anemia with bilirubin >20 mg/dL and very low alkaline phosphatase—these suggest Wilson disease 1
  • Wilson disease with fulminant presentation is uniformly fatal without transplantation 1

Autoimmune hepatitis:

  • ANA, anti-smooth muscle antibody, IgG levels 1
  • Consider liver biopsy if stable enough (look for interface hepatitis, plasma cells, rosettes) 1

Etiology-Specific Management

Viral Hepatitis A or B

  • Supportive care only—no proven virus-specific treatment 1
  • Do NOT use nucleoside analogs for acute hepatitis B in the fulminant setting 1
  • Lamivudine may be considered for acute hepatitis B without encephalopathy, but evidence is limited 1

HSV/VZV

  • IV acyclovir immediately 1
  • Immediate transplant listing—this is uniformly fatal without transplant 1

Wilson Disease

  • Do NOT use penicillamine—risk of hypersensitivity and ineffective in acute setting 1
  • Consider albumin dialysis, continuous hemofiltration, or plasma exchange to lower copper acutely 1
  • List for urgent transplantation immediately—recovery without transplant is extremely rare 1

Autoimmune Hepatitis

Critical decision point based on encephalopathy grade:

  • If encephalopathy grade 0-II: Start prednisone 40-60 mg/day AND list for transplant 1, 5
  • If encephalopathy grade III-IV: Do NOT give corticosteroids—list for urgent transplant only 5
  • The 2024 EASL guidelines are clear: severe coagulopathy with grade III-IV encephalopathy is a contraindication to steroids 5

Drug-Induced (Non-Acetaminophen)

  • Discontinue all non-essential medications 1
  • Supportive care only

Supportive Care Protocol

Cerebral Edema Prevention (Leading Cause of Death)

  • Monitor for grade III-IV encephalopathy
  • Consider intracranial pressure monitoring if grade III-IV encephalopathy develops
  • Maintain cerebral perfusion pressure >50-60 mmHg
  • Elevate head of bed 30 degrees
  • Avoid hypotonic fluids
  • Consider therapeutic hypothermia in specialized centers

Metabolic Management

  • Monitor and correct hypoglycemia aggressively (check glucose q1-2h)
  • Correct coagulopathy only if active bleeding or before procedures—routine correction may worsen outcomes
  • Maintain near-normal metabolic milieu for hepatic regeneration 6

Infection Surveillance

  • High index of suspicion—infections occur late and worsen prognosis 6
  • Low threshold for empiric antibiotics and antifungals
  • Surveillance cultures every 48 hours

Renal Support

  • Early continuous renal replacement therapy if needed
  • Avoid nephrotoxins

Extracorporeal Support

Consider plasma exchange or molecular adsorbent recirculating system (MARS) as bridge to transplant or recovery 7, 2:

  • Plasma exchange showed remarkable improvement in young adults with hepatitis A fulminant failure 7
  • Use 3-5 sessions with 1.5-2L fresh frozen plasma per session 7
  • Can be initiated early when encephalopathy first develops 7

Transplant Listing Criteria

List immediately if ANY of the following (King's College Criteria):

For non-acetaminophen causes:

  • INR >6.5 (regardless of encephalopathy grade), OR
  • Any 3 of: Age <10 or >40 years, non-A/non-B hepatitis, drug reaction, jaundice >7 days before encephalopathy, INR >3.5, bilirubin >17.5 mg/dL

Additional urgent listing indications:

  • Wilson disease with fulminant presentation 1
  • HSV/VZV hepatitis 1
  • Autoimmune hepatitis not responding to steroids within 48-72 hours 5

Common Pitfalls

  1. Delaying transfer to transplant center—this is the most critical error
  2. Missing Wilson disease in young adults—always screen, even without Kayser-Fleischer rings (present in only 50%) 1
  3. Giving corticosteroids to autoimmune hepatitis patients with grade III-IV encephalopathy—this worsens outcomes 5
  4. Starting penicillamine for Wilson disease in acute setting—use plasma exchange instead 1
  5. Assuming hepatitis C causes fulminant failure—it does not 1
  6. Missing HSV hepatitis because no skin lesions—lesions absent in 50% of cases 1
  7. Waiting too long to list for transplant—survival with transplant is 75-80% vs 10-20% without 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.